- Home
- GANX vs CNTY Comparison
GANX vs CNTY Comparison
Compare GANX & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- CNTY
- Stock Information
- Founded
- GANX 2017
- CNTY 1992
- Country
- GANX United States
- CNTY United States
- Employees
- GANX N/A
- CNTY N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- CNTY Hotels/Resorts
- Sector
- GANX Health Care
- CNTY Consumer Discretionary
- Exchange
- GANX Nasdaq
- CNTY Nasdaq
- Market Cap
- GANX 45.8M
- CNTY 46.3M
- IPO Year
- GANX 2021
- CNTY 1993
- Fundamental
- Price
- GANX $1.95
- CNTY $1.52
- Analyst Decision
- GANX Strong Buy
- CNTY Strong Buy
- Analyst Count
- GANX 5
- CNTY 6
- Target Price
- GANX $8.20
- CNTY $5.17
- AVG Volume (30 Days)
- GANX 314.5K
- CNTY 96.0K
- Earning Date
- GANX 05-13-2025
- CNTY 05-12-2025
- Dividend Yield
- GANX N/A
- CNTY N/A
- EPS Growth
- GANX N/A
- CNTY N/A
- EPS
- GANX N/A
- CNTY N/A
- Revenue
- GANX N/A
- CNTY $575,919,000.00
- Revenue This Year
- GANX N/A
- CNTY $8.17
- Revenue Next Year
- GANX N/A
- CNTY $4.43
- P/E Ratio
- GANX N/A
- CNTY N/A
- Revenue Growth
- GANX N/A
- CNTY 4.67
- 52 Week Low
- GANX $0.89
- CNTY $1.30
- 52 Week High
- GANX $3.19
- CNTY $5.09
- Technical
- Relative Strength Index (RSI)
- GANX 54.26
- CNTY 48.10
- Support Level
- GANX $1.85
- CNTY $1.41
- Resistance Level
- GANX $2.27
- CNTY $1.53
- Average True Range (ATR)
- GANX 0.16
- CNTY 0.06
- MACD
- GANX 0.02
- CNTY 0.05
- Stochastic Oscillator
- GANX 59.17
- CNTY 74.00
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.